Login to your account Try before you buy 7 day trial access Become a subscriber Or 77 per month The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products
The litigation continues to evolve as additional plaintiffs file claims involving GLP-1 medications manufactured by Novo Nordisk and Eli Lilly, including Ozempic, Wegovy, Mounjaro, Zepbound, and related drugs
Ninety-seven percent had ascites, 64% had hepatic encephalopathy, 9% had portal hypertensive bleeding, and 58% met the NACSELD definition of ACLF
Bridge medication coverage is the same regardless of which tier you qualify under
They must ensure their products are safe and that label claims are not misleading, but the burden of proving a product is unsafe falls on the FDA, not the manufacturer
With over 42% of adults in the United States classified as obese, finding effective weight loss solutions is more important than ever